Table 5.
Cross-Correlation Analyses between Different Protein Biomarkers
| Peak serum levels | ||||||
|---|---|---|---|---|---|---|
| S100B | NSE | GFAP | UCH-L1 | Tau | NF-L | |
| S100B | 1.000 | |||||
| NSE | 0.458 | 1.000 | ||||
| GFAP | 0.670 | 0.496 | 1.000 | |||
| UCH-L1 | 0.665 | 0.486 | 0.880 | 1.000 | ||
| Tau | 0.632 | 0.548 | 0.824 | 0.877 | 1.000 | |
| NF-L | 0.279 | 0.282 | 0.297 | 0.383 | 0.438 | 1.000 |
Cross-correlation analyses displaying Spearman's rho correlation coefficient for peak serum levels for each patient. This was done in patients where all biomarker levels where present, thus n = 168.
GFAP, glial fibrillary acidic protein; NF-L, neurofilament-light; NSE, neuron-specific enolase; S100B, S100 calcium-binding protein B; UCH-L1, ubiquitin carboxyl-terminal hydrolase-L1.